JAK2 is a protein tyrosine kinase, and recent evidence has demonstrated that miR‐101 (3p and 5p were not distinguished) inhibits breast cancer cell proliferation and promotes apoptosis by targeting JAK2 49. Here, JAK2 is linked to breast carcinoma.